Current Oncology Reports
Overview
Current Oncology Reports is a peer-reviewed journal that provides concise and up-to-date reviews on various aspects of oncology. It covers recent advancements in cancer research, treatment modalities, and emerging therapies. The journal aims to keep healthcare professionals informed about the latest developments in the field, facilitating better patient care and outcomes.
Details
Details
Abbr.
Curr Oncol Rep
Publisher
Current Science
Start
1999
End
Continuing
Frequency
Bimonthly
p-ISSN
1523-3790
e-ISSN
1534-6269
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 4576
77
SJR / Ranks: 1965
1498
CiteScore / Ranks: 2064
8.40
JIF / Ranks: 1761
4.7
Recent Articles
1.
Jaber N, Saadani H, Schats W, Aalbersberg E, Stokkel M
Curr Oncol Rep
. 2025 Mar;
PMID: 40072700
Purpose: The aim of this review is to provide an overview of novel clinical PET tracers in the pipeline for melanoma. Secondarily, to provide a head-to-head comparison with the current...
2.
Elmenawi S, Fawzy M
Curr Oncol Rep
. 2025 Mar;
PMID: 40064818
Purpose Of Review: This review provides a comprehensive understanding of the ALK gene, encompassing its prevalence, genetic alterations, and significance in neuroblastoma diagnosis, outcome prediction, and targeted therapy utilization. The...
3.
Chinas N, Kaliampou S, Nikolaou V
Curr Oncol Rep
. 2025 Mar;
PMID: 40055269
Purpose Of Review: Cutaneous T-Cell Lymphoma (CTCL) poses challenges both in diagnosis and prognosis. The purpose of this review is to address the role of profiling immune and non-immune cells...
4.
Anastasiou I, Kounatidis D, Vallianou N, Skourtis A, Dimitriou K, Tzivaki I, et al.
Curr Oncol Rep
. 2025 Feb;
PMID: 40014232
Purposeof Review: Ultra-processed foods (UPFs) are becoming more and more important in daily diets around the world; in some cases, they can account for as much as 60% of daily...
5.
Zhu X, Ding C, Aggarwal R
Curr Oncol Rep
. 2025 Feb;
PMID: 40011325
Purpose Of Review: Treatment-emergent neuroendocrine prostate cancer (NEPC) is aggressive and lethal. As androgen receptor signaling inhibitors (ARSIs) are increasingly used in earlier disease settings, treatment-emergent NEPC becomes more prevalent,...
6.
Chen A
Curr Oncol Rep
. 2025 Feb;
PMID: 40000561
Purpose Of Review: Although it is now firmly established that the presence of human papillomavirus (HPV) expression in oropharyngeal cancer is associated with a favorable prognosis, the implications with respect...
7.
Zhou Z, Qin P, Cheng X, Shao M, Ren Z, Zhao Y, et al.
Curr Oncol Rep
. 2025 Feb;
PMID: 39998782
Purpose Of Review: This study aims to systematically review the trajectory of artificial intelligence (AI) development in the medical field, with a particular emphasis on ChatGPT, a cutting-edge tool that...
8.
Wu B, Chen X, Cao C
Curr Oncol Rep
. 2025 Feb;
PMID: 39998781
Purpose Of Review: Nasopharyngeal carcinoma (NPC), characterized by its aggressive nature and sensitivity to radiation, demands accurate staging for optimal clinical outcomes. The purpose of this review was to provides...
9.
OLoughlin L, Abel M, Madan R, Einstein D
Curr Oncol Rep
. 2025 Feb;
PMID: 39985705
Purpose Of Review: We evaluate unique clinical and drug development challenges in biochemically recurrent (BCR) prostate cancer. We examine risk stratification, critically appraise trials, and outline ongoing and future development...
10.
Strauss G, George S
Curr Oncol Rep
. 2025 Feb;
PMID: 39985704
Purpose Of Review: This review aims to outline the current understanding of the molecular drivers and treatment paradigms of gastrointestinal stromal tumors, with a focus on recent developments in treatment...